Postpartum depression

New England Journal of Medicine

Volumn 347, Issue 3, 2002, Pages 194-199

  Wisner, Katherine L ^a   Parry, Barbara L ^b   Piontek, Catherine M ^c  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; ESTRADIOL; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AFFECTIVE NEUROSIS; AGITATION; ANOREXIA; ARTICLE; CASE REPORT; CHILDBIRTH; CLINICAL FEATURE; CONSTIPATION; CRYING; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DROWSINESS; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG USE; FATIGUE; FEMALE; GUILT; HUMAN; NAUSEA; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUERPERAL DEPRESSION; RISK FACTOR; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SLEEP DISORDER; SOMNOLENCE; SUICIDAL BEHAVIOR; SWEATING; SYMPTOM; TREATMENT INDICATION; VERTIGO; XEROSTOMIA; BREAST FEEDING; BREAST MILK; CHEMISTRY; PSYCHOTHERAPY; REVIEW;

ANTIDEPRESSIVE AGENTS; BREAST FEEDING; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; MILK, HUMAN; PSYCHOTHERAPY;

EID: 0037130113     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcp011542     Document Type: Article

References (48)

1. Rates and risk of postpartum depression: A meta analysis
2. Epidemiology of puerperal psychoses
3. Symptomatology of affective and psychotic illnesses related to childbearing
4. Effects of gonadal steroids in women with a history of postpartum depression
5. Life stress as a risk factor for postpartum depression: Current research and methodological issues
6. Psychobiology of postpartum mood disorders
7. Detection of postnatal depression: Development of the 10-item Edinburgh Postnatal Depression Scale
8. Origins and development of the 10-item Edinburgh Postnatal Depression Scale
9. Prevention of recurrent postpartum depression: A randomized clinical trial
10. Postpartum psychiatric syndromes
11. Psychiatric episodes in women with young children
12. Pharmacology of antidepressants - Characteristics of the ideal drug
13. 450 system
14. Differences in interactions of SSRIs
15. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression
16. Sertraline in the treatment of women with postpartum major depression
17. Venlafaxine in the treatment of postpartum depression
18. Tricyclics vs SSRIs for postpartum depression
19. Effects of the postpartum period on nortriptyline pharmacokinetics
20. Guidelines for the treatment of patients with major depressive disorder (revision)
21. Efficacy of interpersonal psychotherapy for postpartum depression
22. Serum sertraline and N-desmethylsertraline levels in breast-feeding mother-infant pairs
23. Sertraline and desmethylsertraline in human breast milk and nursing infants
24. Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs
25. Use of sertraline, paroxetine and fluvoxamine by nursing women
26. Paroxetine in human breast milk and nursing infants
27. Paroxetine levels in postpartum depressed women, breast milk, and infant serum
28. Possible association between fluoxetine hydrochloride and colic in an infant
29. Distribution and excretion of fluoxetine and norfluoxetine in human milk
30. Serum fluvoxamine levels in breastfed infants
31. Citalopram and desmethylcitalopram concentrations in breast milk and in serum of mother and infant
32. Citalopram and breast-feeding: Serum concentration and side effects in the infant
33. Venlafaxine and breast-feeding
34. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk
35. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants
36. Citalopram and demethylcitalopram in human milk: Distribution, excretion and effects in breast fed infants
37. Drowsiness and poor feeding in a breast-fed infant: Association with nefazodone and its metabolites
38. Antidepressant treatment during breast-feeding
39. The Expert Consensus Guideline Series: Treatment of depression in women
40. Weight gain in infants breastfed by mothers who take fluoxetine
41. Investigation ofpharmacokinetics and of possible adverse effects in infants exposed to tricyclic antidepressants in breast-milk
42. Postpartum depression in women receiving public assistance: Pilot study of an interpersonal-therapy-oriented group intervention
43. Transdermal oestrogen for treatment of severe postnatal depression
44. A double-blind randomised placebo controlled trial of postnatal norethisterone enanthate: The effect on postnatal depression and serum hormones